Green Tea Extract for Endometriosis Treatment

Launched by CHINESE UNIVERSITY OF HONG KONG · Jul 11, 2016

Keywords

ClinConnect Summary

Women with endometrioma will be randomised into either the experimental group or the placebo comparator group in a 1:1 ratio. The subjects will be given SUNPHENON EGCg or placebo for 3 months prior to their planned surgery.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Complaints of pelvic pain, dysmenorrhoea and/or dyspareunia ≥ 6 months; and
• • Verbal pain rating scale \> 4/10 and visual analogue pain scale \> 4cm; and
• • Ultrasound confirmed endometrioma with or without fibroid and adenomyoma; and
• • Planned surgery treatment within 4-6 months
• Exclusion Criteria:
• • Age \< 20 years beyond or \>40 year behind the active reproductive age; or
• • BMI \<18.5 kg/m2 as underweight or \>25 kg/m2 as overweight; or
• • Chronic pelvic pain or low back pain due to other medical conditions, e.g. urological disorders and orthopaedic disorders; or
• • Secondary dysmenorrhoea due to gynaecological conditions other than endometriosis, e.g. pelvic inflammatory diseases, genitourinary infections, gynaecological tumours, etc.; or
• • Primary dysmenorrhoea without any underlying disease identified; or
• • Ultrasound suggested polycystic ovary, haemorrhagic ovarian cyst, ovarian dermoid cyst, cystic neoplasm, tubo-ovarian abscess or other ovarian pathologies in the same ovary; or
• • Chronic medical conditions under long-term medications; or
• • Endometriosis under active medication in past 1 month; or
• • History of herbal medicine intake in past 1 month